← Leaderboards
Vasu Nair
University Of Iowa
$2,479,815
Attributed
$2,479,815
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,479,815 · 4
By mechanism
R01$1,933,617 · 2
U01$328,518 · 1
R21$217,680 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- M. Todd Washington$6,690,608
- Richard E Kerber$3,762,105
- Jeffrey E Pessin$38,223,856
- Aloysius John Klingelhutz$4,574,727
- George J Weiner$29,916,936
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionAntiaids AgentPharmacokineticsNuclear Magnetic Resonance SpectroscopyIntegraseX Ray CrystallographyHuman Immunodeficiency VirusEnzyme InhibitorsHuman Immunodeficiency Virus 2Dna Directed Dna PolymeraseEnzyme ActivityHuman Immunodeficiency Virus 12'3'DideoxynucleosideProdrugsRna Directed Dna PolymeraseStereochemistryTissue /Cell CultureUltraviolet SpectrometryElectrospray Ionization Mass SpectrometryOxidoreductase InhibitorAntiviral AgentsNucleoside AnalogPoxviridaeCooperative Study
Grant awards (14)
Viral Replication Inhibitors Targeted at HIV Integrase$253,400
R01 · FY2004 · AI
PHOSPHORYLATED ISONUCLEOSIDES: NEW ANTI-HIV AGENTS$253,400
R01 · FY2003 · AI
Viral Replication Inhibitors Targeted at HIV Integrase$253,400
R01 · FY2003 · AI
PHOSPHORYLATED ISONUCLEOSIDES: NEW ANTI-HIV AGENTS$232,284
R01 · FY2002 · AI
Viral Replication Inhibitors Targeted at HIV Integrase$232,284
R01 · FY2002 · AI
Inhibitors of IMPDH as antiorthopoxvirus agents$109,506
U01 · FY2002 · AI
Viral Replication Inhibitors Targeted at HIV Integrase$21,437
R01 · FY2002 · AI
PHOSPHORYLATED ISONUCLEOSIDES: NEW ANTI-HIV AGENTS$21,202
R01 · FY2002 · AI
Viral Replication Inhibitors Targeted at HIV Integrase$257,250
R01 · FY2001 · AI
PHOSPHORYLATED ISONUCLEOSIDES: NEW ANTI-HIV AGENTS$202,125
R01 · FY2001 · AI
Inhibitors of IMPDH as antiorthopoxvirus agents$109,506
U01 · FY2001 · AI
PHOSPHORYLATED ISONUCLEOSIDES--NEW ANTI-HIV AGENTS$217,680
R21 · FY2000 · AI
VIRAL REPLICATION INHIBITORS TARGETED AT HIV INTEGRASE$206,835
R01 · FY2000 · AI
Inhibitors of IMPDH as antiorthopoxvirus agents$109,506
U01 · FY2000 · AI